APP-led benign hematology consults boost access in community oncology—cut wait times, expand capacity, and show how teams scale safely.
Eileen Vella, MS, PA-C
Advertisement
Articles by Eileen Vella, MS, PA-C
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
3
Intranasal NEO100 Meets Primary End Point in Recurrent IDH1-Mutant Glioma
4
ASTRO Issues Updated Clinical Practice Guideline on RT for Pancreatic Cancer
5